Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage

Liang Dong, Yong Zhou, Zhao Qiong Zhu, Tian Liu, Jia Xi Duan, Jun Zhang, Ping Li, Bruce D. Hammcok, Cha Xiang Guan

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Triggering receptors expressed on myeloid cell-1 (TREM-1) is a superimmunoglobulin receptor expressed on myeloid cells. TREM-1 amplifies the inflammatory response. Epoxyeicosatrienoic acids (EETs), the metabolites of arachidonic acid derived from the cytochrome P450 enzyme, have anti-inflammatory properties. However, the effects of EETs on TREM-1 expression under inflammatory stimulation remain unclear. Therefore, inhibition of soluble epoxide hydrolase (sEH) with a highly selective inhibitor [1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea, TPPU] was used to stabilize EETs. LPS was intratracheally injected into mice to induce pulmonary inflammation, after TPPU treatment for 3 h. Histological examination showed TPPU treatment-alleviated LPS-induced pulmonary inflammation. TPPU decreased TREM-1 expression, but not DAP12 or MyD88 expression. Murine peritoneal macrophages were challenged with LPS in vitro. We found that TPPU reduced LPS-induced TREM-1 expression in a dose-dependent manner, but not DAP12 or MyD88 expression. TPPU also decreased downstream signal from TREM-1, reducing pro-inflammatory cytokine TNF-α and IL-1β mRNA expression. Furthermore, TPPU treatment inhibited IkB degradation in vivo and in vitro. Our results indicate that the inhibition of sEH suppresses LPS-induced TREM-1 expression and inflammation via inhibiting NF-kB activation in murine macrophage.

Original languageEnglish (US)
Pages (from-to)13-20
Number of pages8
JournalInflammation
Volume40
Issue number1
DOIs
StatePublished - Feb 1 2017

Fingerprint

Epoxide Hydrolases
NF-kappa B
Myeloid Cells
Macrophages
Cytochrome P-450 Enzyme System
Pneumonia
Peritoneal Macrophages
Interleukin-1
Arachidonic Acid
Urea
Anti-Inflammatory Agents
Cytokines
Inflammation
Messenger RNA
Acids

Keywords

  • epoxyeicosatrienoic acids
  • inflammation
  • macrophage
  • soluble epoxide hydrolase inhibitor
  • triggering receptor expressed on myeloid cells-1

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage. / Dong, Liang; Zhou, Yong; Zhu, Zhao Qiong; Liu, Tian; Duan, Jia Xi; Zhang, Jun; Li, Ping; Hammcok, Bruce D.; Guan, Cha Xiang.

In: Inflammation, Vol. 40, No. 1, 01.02.2017, p. 13-20.

Research output: Contribution to journalArticle

Dong, Liang ; Zhou, Yong ; Zhu, Zhao Qiong ; Liu, Tian ; Duan, Jia Xi ; Zhang, Jun ; Li, Ping ; Hammcok, Bruce D. ; Guan, Cha Xiang. / Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage. In: Inflammation. 2017 ; Vol. 40, No. 1. pp. 13-20.
@article{6497a916ed4943e1a5bf53be3aa8df06,
title = "Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage",
abstract = "Triggering receptors expressed on myeloid cell-1 (TREM-1) is a superimmunoglobulin receptor expressed on myeloid cells. TREM-1 amplifies the inflammatory response. Epoxyeicosatrienoic acids (EETs), the metabolites of arachidonic acid derived from the cytochrome P450 enzyme, have anti-inflammatory properties. However, the effects of EETs on TREM-1 expression under inflammatory stimulation remain unclear. Therefore, inhibition of soluble epoxide hydrolase (sEH) with a highly selective inhibitor [1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea, TPPU] was used to stabilize EETs. LPS was intratracheally injected into mice to induce pulmonary inflammation, after TPPU treatment for 3 h. Histological examination showed TPPU treatment-alleviated LPS-induced pulmonary inflammation. TPPU decreased TREM-1 expression, but not DAP12 or MyD88 expression. Murine peritoneal macrophages were challenged with LPS in vitro. We found that TPPU reduced LPS-induced TREM-1 expression in a dose-dependent manner, but not DAP12 or MyD88 expression. TPPU also decreased downstream signal from TREM-1, reducing pro-inflammatory cytokine TNF-α and IL-1β mRNA expression. Furthermore, TPPU treatment inhibited IkB degradation in vivo and in vitro. Our results indicate that the inhibition of sEH suppresses LPS-induced TREM-1 expression and inflammation via inhibiting NF-kB activation in murine macrophage.",
keywords = "epoxyeicosatrienoic acids, inflammation, macrophage, soluble epoxide hydrolase inhibitor, triggering receptor expressed on myeloid cells-1",
author = "Liang Dong and Yong Zhou and Zhu, {Zhao Qiong} and Tian Liu and Duan, {Jia Xi} and Jun Zhang and Ping Li and Hammcok, {Bruce D.} and Guan, {Cha Xiang}",
year = "2017",
month = "2",
day = "1",
doi = "10.1007/s10753-016-0448-6",
language = "English (US)",
volume = "40",
pages = "13--20",
journal = "Inflammation",
issn = "0360-3997",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage

AU - Dong, Liang

AU - Zhou, Yong

AU - Zhu, Zhao Qiong

AU - Liu, Tian

AU - Duan, Jia Xi

AU - Zhang, Jun

AU - Li, Ping

AU - Hammcok, Bruce D.

AU - Guan, Cha Xiang

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Triggering receptors expressed on myeloid cell-1 (TREM-1) is a superimmunoglobulin receptor expressed on myeloid cells. TREM-1 amplifies the inflammatory response. Epoxyeicosatrienoic acids (EETs), the metabolites of arachidonic acid derived from the cytochrome P450 enzyme, have anti-inflammatory properties. However, the effects of EETs on TREM-1 expression under inflammatory stimulation remain unclear. Therefore, inhibition of soluble epoxide hydrolase (sEH) with a highly selective inhibitor [1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea, TPPU] was used to stabilize EETs. LPS was intratracheally injected into mice to induce pulmonary inflammation, after TPPU treatment for 3 h. Histological examination showed TPPU treatment-alleviated LPS-induced pulmonary inflammation. TPPU decreased TREM-1 expression, but not DAP12 or MyD88 expression. Murine peritoneal macrophages were challenged with LPS in vitro. We found that TPPU reduced LPS-induced TREM-1 expression in a dose-dependent manner, but not DAP12 or MyD88 expression. TPPU also decreased downstream signal from TREM-1, reducing pro-inflammatory cytokine TNF-α and IL-1β mRNA expression. Furthermore, TPPU treatment inhibited IkB degradation in vivo and in vitro. Our results indicate that the inhibition of sEH suppresses LPS-induced TREM-1 expression and inflammation via inhibiting NF-kB activation in murine macrophage.

AB - Triggering receptors expressed on myeloid cell-1 (TREM-1) is a superimmunoglobulin receptor expressed on myeloid cells. TREM-1 amplifies the inflammatory response. Epoxyeicosatrienoic acids (EETs), the metabolites of arachidonic acid derived from the cytochrome P450 enzyme, have anti-inflammatory properties. However, the effects of EETs on TREM-1 expression under inflammatory stimulation remain unclear. Therefore, inhibition of soluble epoxide hydrolase (sEH) with a highly selective inhibitor [1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea, TPPU] was used to stabilize EETs. LPS was intratracheally injected into mice to induce pulmonary inflammation, after TPPU treatment for 3 h. Histological examination showed TPPU treatment-alleviated LPS-induced pulmonary inflammation. TPPU decreased TREM-1 expression, but not DAP12 or MyD88 expression. Murine peritoneal macrophages were challenged with LPS in vitro. We found that TPPU reduced LPS-induced TREM-1 expression in a dose-dependent manner, but not DAP12 or MyD88 expression. TPPU also decreased downstream signal from TREM-1, reducing pro-inflammatory cytokine TNF-α and IL-1β mRNA expression. Furthermore, TPPU treatment inhibited IkB degradation in vivo and in vitro. Our results indicate that the inhibition of sEH suppresses LPS-induced TREM-1 expression and inflammation via inhibiting NF-kB activation in murine macrophage.

KW - epoxyeicosatrienoic acids

KW - inflammation

KW - macrophage

KW - soluble epoxide hydrolase inhibitor

KW - triggering receptor expressed on myeloid cells-1

UR - http://www.scopus.com/inward/record.url?scp=84989157868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989157868&partnerID=8YFLogxK

U2 - 10.1007/s10753-016-0448-6

DO - 10.1007/s10753-016-0448-6

M3 - Article

VL - 40

SP - 13

EP - 20

JO - Inflammation

JF - Inflammation

SN - 0360-3997

IS - 1

ER -